Product Information
AJOVY 225 MG/1.5 ML SYRINGE is a brand product labeled by Teva Pharmaceuticals USA Inc., priced at $508.5072 per ML under NDC 51759020410. Its NADAC has been published 407 times since Dec 19, 2018.
Strength
225 mg/1.5mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
51759020410
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
FREMANEZUMABApproval Type
Biologic (BLA)
FDA Application
BLA761089On Market Since
9/15/2018
Price Statistics
The NADAC for AJOVY 225 MG/1.5 ML SYRINGE has been published 407 times since Dec 19, 2018, and over the history we have for it it has risen 37.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $508.5072 per ML |
|---|---|
| All-time high | $508.6071 (Jul 15, 2026) |
| All-time low | $369.4106 (Oct 23, 2019) |
| 52-week high | $508.6071 |
| 52-week low | $484.1923 |
| Median price | $429.2732 |
| Average price | $435.6168 |
| Largest weekly change | +5.0% (Jan 7, 2026) |
| Weeks tracked | 407 |
| Tracking since | Dec 19, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fremanezumab-vfrm market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AJOVY 225 MG/1.5 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for AJOVY 225 MG/1.5 ML SYRINGE, manufactured by Teva Pharmaceuticals USA Inc., is $508.5072 per ML (NDC 51759020410), effective Sep 30, 2026.
How has the price of AJOVY 225 MG/1.5 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for AJOVY 225 MG/1.5 ML SYRINGE has risen 37.5%. It has been tracked across 407 weekly CMS publications since Dec 19, 2018.
What are the highest and lowest recorded NADAC prices for AJOVY 225 MG/1.5 ML SYRINGE?
Since Dec 19, 2018, the NADAC for AJOVY 225 MG/1.5 ML SYRINGE has ranged from a low of $369.4106 (Oct 23, 2019) to a high of $508.6071 (Jul 15, 2026), with a median of $429.2732 per ML.
Are there cheaper alternatives to AJOVY 225 MG/1.5 ML SYRINGE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AJOVY 225 MG/1.5 ML AUTOINJECTOR (3 PACK), is $507.4470 per ML — about 0% below AJOVY 225 MG/1.5 ML SYRINGE.
Who manufactures AJOVY 225 MG/1.5 ML SYRINGE?
AJOVY 225 MG/1.5 ML SYRINGE (NDC 51759020410) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a brand product.